Home › Compare › PXMD vs FCPT

PXMD vs FCPT: Dividend Comparison 2026

PXMD yields 285714.29% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PXMD wins by $1.734986541242196e+31M in total portfolio value
10 years
PXMD
PXMD
● Live price
285714.29%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.734986541242196e+31M
Annual income
$17,337,928,197,276,910,000,000,000,000,000,000,000.00
Full PXMD calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — PXMD vs FCPT

📍 PXMD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPXMDFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PXMD + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PXMD pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PXMD
Annual income on $10K today (after 15% tax)
$24,285,714.29/yr
After 10yr DRIP, annual income (after tax)
$14,737,238,967,685,373,000,000,000,000,000,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, PXMD beats the other by $14,737,238,967,685,373,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PXMD + FCPT for your $10,000?

PXMD: 50%FCPT: 50%
100% FCPT50/50100% PXMD
Portfolio after 10yr
$8.67493270621098e+30M
Annual income
$8,668,964,098,638,455,000,000,000,000,000,000,000.00/yr
Blended yield
99.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

PXMD
No analyst data
Altman Z
-176.3
Piotroski
2/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PXMD buys
0
FCPT buys
0
No recent congressional trades found for PXMD or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPXMDFCPT
Forward yield285714.29% ✓6.05%
Annual dividend / share$2.00 ✓$1.43
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$1.734986541242196e+31M$49.1K ✓
Annual income after 10y$17,337,928,197,276,910,000,000,000,000,000,000,000.00 ✓$5,775.28
Total dividends collected$1.734908400352195e+31M$24.1K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: PXMD vs FCPT ($10,000, DRIP)

YearPXMD PortfolioPXMD Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$28,582,129$28,571,428.57$11,401$700.92+$28.57M → PXMD
2$76,351,353,429$76,320,770,551.21$13,064$864.84+$76351.34M → PXMD
3$190,619,493,207,524$190,537,797,259,355.30$15,051$1,072.48+$190619493.19M → PXMD
4$444,781,927,427,195,200$444,577,964,569,463,100.00$17,442$1,337.22+$444781927427.18M → PXMD
5$969,967,353,346,567,200,000$969,491,436,684,220,000,000.00$20,340$1,677.08+$969967353346567.13M → PXMD
6$1,976,961,629,315,093,000,000,000$1,975,923,764,247,012,300,000,000.00$23,880$2,116.57+$1976961629315092992.00M → PXMD
7$3,765,923,944,594,039,000,000,000,000$3,763,808,595,650,671,000,000,000,000.00$28,241$2,689.36+$3.765923944594039e+21M → PXMD
8$6,704,681,437,057,684,000,000,000,000,000$6,700,651,898,436,968,000,000,000,000,000.00$33,660$3,442.07+$6.704681437057683e+24M → PXMD
9$11,156,275,836,497,016,000,000,000,000,000,000$11,149,101,827,359,364,000,000,000,000,000,000.00$40,456$4,439.95+$1.1156275836497015e+28M → PXMD
10$17,349,865,412,421,960,000,000,000,000,000,000,000$17,337,928,197,276,910,000,000,000,000,000,000,000.00$49,063$5,775.28+$1.734986541242196e+31M → PXMD

PXMD vs FCPT: Complete Analysis 2026

PXMD — Stock

PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human african trypanosomiasis. It is also involved in developing PAX-102, an intranasal formulation of suramin for neurologic indications. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC.

Full PXMD Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this PXMD vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PXMD vs SCHDPXMD vs JEPIPXMD vs OPXMD vs KOPXMD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.